AJP - Regu Ad Instruments
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Regul Integr Comp Physiol (October 1, 2008). doi:10.1152/ajpregu.90625.2008
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
295/6/R1822    most recent
90625.2008v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zuberi, Z.
Right arrow Articles by Tinker, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zuberi, Z.
Right arrow Articles by Tinker, A.
Submitted on July 23, 2008
Revised on September 30, 2008
Accepted on September 30, 2008

The role of inhibitory heterotrimeric G-proteins in the control of in-vivo heart rate dynamics

Zia Zuberi, Lutz Birnbaumer, and Andrew Tinker1*

1 University College, London

* To whom correspondence should be addressed. E-mail: a.tinker{at}ucl.ac.uk.

Multiple isoforms of inhibitory G{alpha}-subunits (G{alpha}i1,2,3 as well as G{alpha}o) are present within the heart and their role in modulating pacemaker function remains unresolved. Do inhibitory G{alpha}-subunits selectively modulate parasympathetic heart rate responses? Published findings using a variety of experimental approaches have implicated roles for G{alpha}i2, G{alpha}i3 and G{alpha}o in parasympathetic signal transduction. We have compared in vivo different groups of mice with global genetic deletion of G{alpha}i1/G{alpha}i3, G{alpha}i2 and G{alpha}o against littermate controls using implanted ECG telemetry. Significant resting tachycardia was observed in G{alpha}i2 (-/-) and G{alpha}o (-/-) mice compared with control and G{alpha}i1/G{alpha}i3 (-/-)(-/-) mice (p-value <0.05). Loss of diurnal heart rate variation was seen exclusively in G{alpha}o (-/-) mice. Using heart rate variability (HRV) analysis, compared to littermate controls (4.02ms±21.17(n=6), G{alpha}i2 (-/-) mice have a selective attenuation of HF power (0.73ms2±0.31(n=5)), p-value<0.05). G{alpha}i1/G{alpha}i3 (-/-)(-/-) and G{alpha}o (-/-) cohorts have non-significant changes in HF power. G{alpha}o (-/-) mice have a different basal HRV signature. The observed HRV phenotype in G{alpha}i2 (-/-) mice was qualitatively similar to atropine (1mg/kg) treated controls (and mice treated with the GIRK channel blocker tertiapinQ (0.05mg/kg)). Maximal cardio-inhibitory response to the M2-receptor agonist carbachol (0.5mg/kg) compared to basal heart rate was attenuated in G{alpha}i2 (-/-) mice (0.08+/-0.04(n=6)) compares to control (0.27+/-0.04 (n=7) p-value<0.05). Our data suggests a selective defect of parasympathetic heart rate modulation in mice with G{alpha}i2 deletion. Mice with G{alpha}o deletion also have a defect in short term heart rate dynamics but this is qualitatively different to the effects of atropine, tertiapinQ and G{alpha}i2 deletion. In contrast G{alpha}i1 and G{alpha}i3 do not appear to be essential for parasympathetic responses in vivo.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 2008 by the American Physiological Society.